idarubicin has been researched along with Shock, Septic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, EK; Lee, JH; Park, J; Shin, DB; Sym, SJ; Yi, HS | 1 |
| Aziz, A; Gosbell, IB; Sanghavi, R; Varghese, B | 1 |
| Carrascosa, JM; Ferrándiz, C; Guinovart, RM | 1 |
| Koyama, M; Matsuo, K; Murata, Y; Shimoya, K; Ueda, S; Wada, K | 1 |
4 other study(ies) available for idarubicin and Shock, Septic
| Article | Year |
|---|---|
Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Digestive System Surgical Procedures; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Mucormycosis; Neutropenia; Rhinitis; Shock, Septic; Sinusitis; Typhlitis | 2010 |
Toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus in a patient with pancytopenia.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cross Infection; Cytarabine; Etoposide; Fatal Outcome; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Methicillin-Resistant Staphylococcus aureus; Multiple Organ Failure; Pancytopenia; Shock, Septic; Staphylococcal Infections | 2010 |
[Leukemia cutis arising at the site of injection of a tetanus vaccine booster].
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Fatal Outcome; Humans; Idarubicin; Immunization, Secondary; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Leukosialin; Male; Middle Aged; Radiotherapy, Adjuvant; Shock, Septic; Skin; Tetanus Toxoid | 2010 |
Idarubicin administered during pregnancy: its effects on the fetus.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Drug Therapy, Combination; Female; Fetus; Gestational Age; Heart Rate, Fetal; Humans; Idarubicin; Leukemia, Myeloid, Acute; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Shock, Septic; Treatment Outcome | 2004 |